24
Participants
Start Date
August 16, 2011
Primary Completion Date
April 14, 2017
Study Completion Date
April 14, 2017
TPI 287
"Starting dose Phase I: 160 mg/m2 by vein over 60 minutes on Days 1, 8, and 15 of every 28 day cycle.~Starting Dose Phase II: Maximum tolerated dose from Phase I."
Dexamethasone
6 mg by mouth at 12 hours and 6 hours prior to treatment. As alternative and based on the treating physician discretion, dexamethasone 10 mg by vein may be given 30-60 minutes prior to treatment with TPI 287.
Benadryl
12.5-25 mg intravenous (IV) push 30-60 minutes prior
Ranitidine
As H2 blocker 1mg/kg IV 30-60 minutes prior
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Cortice Biosciences, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER